These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 2894736

  • 1. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
    Uchitomi Y, Yamawaki S.
    Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736
    [Abstract] [Full Text] [Related]

  • 2. Chronic lithium treatment enhances the postsynaptic 5-HT1A receptor-mediated 5-HT behavioral syndrome induced by 8-OH-DPAT in rats via catecholaminergic systems.
    Uchitomi Y, Yamawaki S.
    Psychopharmacology (Berl); 1993 Sep; 112(1):74-9. PubMed ID: 7871012
    [Abstract] [Full Text] [Related]

  • 3. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F, Jeanrenaud B.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [Abstract] [Full Text] [Related]

  • 4. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    Scott PA, Chou JM, Tang H, Frazer A.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316
    [Abstract] [Full Text] [Related]

  • 5. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J, Sugimoto Y, Horisaka K.
    Eur J Pharmacol; 1988 Sep 23; 154(3):299-304. PubMed ID: 2976671
    [Abstract] [Full Text] [Related]

  • 6. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R, Brocco M, Lefèbvre de Ladonchamps B, Monneyron S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov 23; 275(2):822-31. PubMed ID: 7473172
    [Abstract] [Full Text] [Related]

  • 7. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
    Tricklebank MD, Forler C, Fozard JR.
    Eur J Pharmacol; 1984 Nov 13; 106(2):271-82. PubMed ID: 6241568
    [Abstract] [Full Text] [Related]

  • 8. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
    Yokota N, Yamawaki S, Hayakawa H, Yoshida R, Sarai K.
    Yakubutsu Seishin Kodo; 1989 Jun 13; 9(2):197-206. PubMed ID: 2530729
    [Abstract] [Full Text] [Related]

  • 9. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar 13; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

  • 10. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S, Sharp T, Hacksell U.
    Eur J Pharmacol; 1989 Nov 07; 170(3):269-74. PubMed ID: 2533557
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
    Czyrak A, Skuza G, Rogóz Z, Frankiewicz T, Maj J.
    Arzneimittelforschung; 1994 Feb 07; 44(2):113-8. PubMed ID: 7511901
    [Abstract] [Full Text] [Related]

  • 12. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
    Björk L, Cornfield LJ, Nelson DL, Hillver SE, Andén NE, Lewander T, Hacksell U.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):58-65. PubMed ID: 1830099
    [Abstract] [Full Text] [Related]

  • 13. Hypotensive effects of 5-HT1A receptor agonists on the ventrolateral medullary pressor area in dogs.
    Dabiré H, Laubie M, Schmitt H.
    J Cardiovasc Pharmacol; 1990 Jul 01; 15 Suppl 7():S61-7. PubMed ID: 1702488
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by repeated lithium treatment in rats.
    Fujii T, Nakai K, Nakajima Y, Kawashima K.
    Can J Physiol Pharmacol; 2000 May 01; 78(5):392-9. PubMed ID: 10841434
    [Abstract] [Full Text] [Related]

  • 15. The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(DI-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat.
    Przegaliński E, Ismaiel AM, Chojnacka-Wójcik E, Budziszewska B, Tatarczyńska E, Błaszczyńska E.
    Neuropharmacology; 1990 Jun 01; 29(6):521-6. PubMed ID: 2143565
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E, Budziszewska B, Warchoł-Kania A, Błaszczyńska E.
    Pharmacol Biochem Behav; 1989 Jun 01; 33(2):329-34. PubMed ID: 2530590
    [Abstract] [Full Text] [Related]

  • 17. [8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)-induced clonic seizure in mice].
    Fujii E, Nomoto T.
    Yakubutsu Seishin Kodo; 1991 Feb 01; 11(1):29-35. PubMed ID: 1831945
    [Abstract] [Full Text] [Related]

  • 18. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H.
    J Pharmacol Exp Ther; 1994 Mar 01; 268(3):1432-43. PubMed ID: 8138956
    [Abstract] [Full Text] [Related]

  • 19. Influence of the aliphatic spacer length on the 5-HT1A receptor activity of new arylpiperazines with an indazole system.
    Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E.
    Pol J Pharmacol; 2000 Mar 01; 52(3):209-16. PubMed ID: 11055578
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T.
    J Pharmacol Exp Ther; 1998 Mar 01; 284(3):1082-94. PubMed ID: 9495870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.